首页> 美国卫生研究院文献>Ancient Science of Life >STANDARDIZATION AND BIOAVAILABILITY OF AYURVEDIC DRUG LAUHA BHASMA- PART –II COMPARATIVE BIOAVAILABILITY STUDIES
【2h】

STANDARDIZATION AND BIOAVAILABILITY OF AYURVEDIC DRUG LAUHA BHASMA- PART –II COMPARATIVE BIOAVAILABILITY STUDIES

机译:阿育吠陀药物Lauha BhamSMA的标准化和生物利用度-第二部分比较生物利用度的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

After analyzing the Lauha Bhasma samples qualitatively and quantitatively, in-vivo studies on healthy adult male rabbits were carried out. Randomly selected anaemic rabbits were divided into different groups and three variants of Lauha Bhasma and ferrous sulphate sample were administered to each group. The effect of each formulation was monitored by measuring the haemoglobin (Hb) content spectrophotometrically (cyanomethaemoglobin method). Increase in the haemoglobin content was found to be significant in case of the ayurvedic formulations as compared to the ferrous sulphate sample.
机译:在定性和定量分析Lahaha Bhasma样本后,对健康成年雄性兔子进行了体内研究。将随机选择的贫血兔分为不同的组,并给每组分别施用Lauha Bhasma和硫酸亚铁样品的三种变体。通过分光光度法测定血红蛋白(Hb)含量(氰化血红蛋白法)来监测每种制剂的效果。阿育吠陀制剂的血红蛋白含量与硫酸亚铁样品相比明显增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号